PubMed Health⌕ Search

PubMed · 15190185

Does Makeham make sense?

Abstract

Numerical modeling was used to explore the behavior of ideal cohorts obeying the Gompertz-Makeham (GM) law of mortality (-dn/dt 1/n(t) = C + lambda egammat) supplemented with the Strehler-Mildvan (SM) correlation (ln lambda = A - Bgamma) and to show how changes in the age-independent parameter C will produce an apparent SM correlation if C is ignored in mortality data treatment as in the case of the so-called longitudinal gompertzian analysis of historical changes in human mortality patterns. The essential difference between the Makeham term C and Gompertz term lambda e(gammat) has been suggested to be not that the latter is age-dependent whereas the former is not, but that C comprises the contributions of inherently irresistible stresses to mortality, whereas lambda e(gammat) comprises the contributions of resistible stresses and shows how changes in the resistance to them are translated into changes in mortality. This assumption was used to show by modeling how the transition of stresses from irresistible to resistible may result in decreased late survivorship as the cost of increased early survivorship, in line with the antagonistic pleiotropy theory of aging. On the whole, the modeling suggests that the GM equation is not only a mathematical tool for treatment of mortality data but that it also has a fundamental biological significance, and its Makeham term C should not be ignored in any analysis of mortality data.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Golubev. 2004. Does Makeham make sense?. https://doi.org/10.1023/b%3Abgen.0000031153.63563.58

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort study.

Immunosuppression induced by the human immunodeficiency virus (HIV) increases the risk of developing non-Hodgkin's lymphoma (NHL). As the hepatitis C virus (HCV) has been implicated in the development of B cell lymphomas, we compared the incidence of systemic NHL during HIV infection compared to HIV and HCV co-infection. Of 5,832 individuals studied during the era of highly active anti-retroviral therapy (HAART), 102 patients were diagnosed with systemic NHL. The incidence of systemic NHL was 6.9 of 10(4) patient years during HIV infection compared to 7.1 of 10(4) patient years during HIV alone (p = 0.9). In this immunocompromised patient population, there was no association between HCV infection and an increased risk of lymphoma.

Cohort Studies↗

Generating survival times to simulate Cox proportional hazards models.

Simulation studies present an important statistical tool to investigate the performance, properties and adequacy of statistical models in pre-specified situations. One of the most important statistical models in medical research is the proportional hazards model of Cox. In this paper, techniques to generate survival times for simulation studies regarding Cox proportional hazards models are presented. A general formula describing the relation between the hazard and the corresponding survival time of the Cox model is derived, which is useful in simulation studies. It is shown how the exponential, the Weibull and the Gompertz distribution can be applied to generate appropriate survival times for simulation studies. Additionally, the general relation between hazard and survival time can be used to develop own distributions for special situations and to handle flexibly parameterized proportional hazards models. The use of distributions other than the exponential distribution is indispensable to investigate the characteristics of the Cox proportional hazards model, especially in non-standard situations, where the partial likelihood depends on the baseline hazard. A simulation study investigating the effect of measurement errors in the German Uranium Miners Cohort Study is considered to illustrate the proposed simulation techniques and to emphasize the importance of a careful modelling of the baseline hazard in Cox models.

Cohort Studies↗

Integrating treatment for hepatitis C virus infection into an HIV clinic.

In the United States, one-third of human immunodeficiency virus (HIV)-infected patients are also coinfected with hepatitis C virus (HCV). Of 228 coinfected patients whose charts were reviewed in our 2000 study, only 2 had received therapy with interferon. To address low rates of treatment, in 2001 we implemented a program to shift the primary responsibility for oversight of care for HCV-infected patients from the liver clinic to HIV primary care clinicians and to provide education and support regarding adherence to patients. Critical elements of the program include education of HIV clinicians with regard to treatment for HCV infection, establishment of a coinfection clinic in the HIV clinic, assignment of a full-time Registered Nurse for monitoring and support of patients undergoing treatment for HCV infection, and development of a weekly peer group for the coinfected patients. Preliminary treatment results for patients in the program suggest that this approach has promise for improving outcomes of treatment among coinfected patients.

Cohort Studies↗